Release, metabolism and interconversion of adenine and uridine nucleotides: Implications for G protein-coupled P2 receptor agonist selectivity

Trends in Pharmacological Sciences

Volumn 18, Issue 2, 1997, Pages 43-46

  Harden, T Kendall ^a   Lazarowski, Eduardo R ^a   Boucher, Richard C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE 5' O (2 THIODIPHOSPHATE); ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; GUANINE NUCLEOTIDE BINDING PROTEIN; HEXOKINASE; PURINE P2 RECEPTOR; PURINE P2 RECEPTOR AGONIST; PURINE P24 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RADIOISOTOPE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE NUCLEOTIDE; URIDINE TRIPHOSPHATE;

DRUG SELECTIVITY; HUMAN; MOLECULAR CLONING; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0031081539     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(96)01023-1     Document Type: Short Survey

References (15)

1. 1 Burnstock, G. (1972) Pharmacol. Rev. 24, 509-581
2. 2 Burnstock, G. (1978) Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach (Straub, R. W. and Bolis, L., eds), pp. 107-118, Raven Press
3. 3 Fredholm, B. B. et al. Trends Pharmacol. Sci. (in press)
4. 4 Saiag, B. et al. (1995) Endothelium 2, 279-285
5. 5 Slakey, L. L., Gordon, E. M. and Pearson, J. D. (1990) Ann. New York Acad. Sci. 603, 366-379
6. 6 Dubyak, G. R. and El-Moatassim, C. (1993) Am. J. Physiol. 265, C577-C606
7. 7 Lazarowski, E. R., Watt, W. C., Stutts, M. J., Boucher, R. C. and Harden, T. K. (1995) Br. J. Pharmacol. 116, 1619-1627
8. 8 Lazarowski, E. R., Paradiso, A. M., Watt, W. C., Harden, T. K. and Boucher, R. C. Proc. Natl. Acad. Sci. U. S. A. (in press)
9. 9 Parr, C. E. et al. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 3275-3279
10. 10 Filtz, T. M., Li, Q., Boyer, J. L., Nicholas, R. A. and Harden, T. K. (1994) Mol. Pharmacol. 46, 8-14
11. 11 Nicholas, R. A., Watt, W. C., Lazarowski, E. R., Li, Q. and Harden, T. K. (1996) Mol. Pharmacol. 50, 224-229
12. 12 Communi, D., Pirotton, S., Parmentier, M. and Boeynaems, J. M. (1995) J. Biol. Chem. 270, 30849-30852
13. 13 Nguyen, T. et al. (1995) J. Biol. Chem. 270, 30845-30848
14. 14 Chang, K., Hanaoka, K., Kumada, M. and Takuwa, Y. (1995) J. Biol. Chem. 270, 26152-26158
15. 15 Hourani, S. M. O. and Hall, D. A. (1994) Trends Pharmacol. Sci. 15, 103-108